61338-13-4
61338-13-4 structure
- Name: 1-(3-Carboxypyrid-2-yl)-2-phenyl-4-methyl-piperazine
- Chemical Name: 2-(4-Methyl-2-phenylpiperazin-1-yl)nicotinic acid
- CAS Number: 61338-13-4
- Molecular Formula: C17H19N3O2
- Molecular Weight: 297.352
- Create Date: 2018-07-16 10:17:12
- Modify Date: 2026-07-05 12:44:23
| Name | 2-(4-Methyl-2-phenylpiperazin-1-yl)nicotinic acid |
|---|---|
| Synonyms |
Mirtazapine Impurity 7
1-(3-Carboxy-2-pyridyl)-4-methyl-2-phenylpiperazine 2-(4-methyl-2-phenylpiperazin-1-yl)pyridine-3-carboxylic acid 1-(3-Cboxypyrid-2-Yl)-2-Phenyl-4-Methyl-Piperazine (N-1) Mirtazapine acid 2-(4-Methyl-2-phenyl-1-piperazinyl)nicotinic acid 3-Pyridinecboxylic acid, 2-(4-methyl-2-phenyl-1-piperazinyl) 1-(3-cboxy-2-pyridyl)-4-methyl-2-phenylpiperazine Mirtazapine Cboxylic Acid 1-(3-CBOXYL PYRIDYL-2)-PHENYL-4 METHYL PIPERAZINE (HMA) 2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinecboxylic acid 2-(4-Methyl-2-phenylpiperazin-1-yl)pyridine-3-cboxylic Acid 1-(3-Cboxy pyridyl-2)-2-phenyl-4-methyl Piperazine (N-2 Intermediate) 1-(3-Cboxypyrid-2-yl)-2-phenyl-4-methyl-piperazine Mirtazapine Cboxylic Acid/1-(3-Cboxy-2-pyridyl)-4-methyl-2-phenylpiperazine |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 494.3±45.0 °C at 760 mmHg |
| Molecular Formula | C17H19N3O2 |
| Molecular Weight | 297.352 |
| Flash Point | 252.8±28.7 °C |
| Exact Mass | 297.147736 |
| PSA | 56.67000 |
| LogP | 1.92 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.610 |
| HS Code | 2933599090 |
|---|
|
~90%
61338-13-4 |
| Literature: Singer, Claude; Liberman, Anita; Finkelstein, Nina Patent: US2001/51718 A1, 2001 ; |
|
~%
61338-13-4 |
| Literature: US2002/95038 A1, ; |
|
~%
61338-13-4 |
| Literature: Organic Preparations and Procedures International, , vol. 39, # 4 p. 399 - 402 |
|
~%
61338-13-4 |
| Literature: Organic Preparations and Procedures International, , vol. 39, # 4 p. 399 - 402 |
| Precursor 3 | |
|---|---|
| DownStream 2 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |